Bone marrow review

Dactinomycin, an antineoplastic dmg, was discovered in 1943 and is made in rather pure form by StreptomjcesparvuUus. Dactinomycin has some bacteriostatic antibacterial and antifungal activity, but high toxicity limits its use to antineoplastic therapy. It may be used alone or with other antineoplastics, with or without surgery and synergistic x-ray therapy. Dose limiting bone marrow toxicity may result in low white cell and platelet count. Intestinal mucosal damage also occurs. Reviews of more detailed chemotherapeutic information are available (217—222). 

The first human kidney and bone marrow transplants using cyclosporine were reported in 1978. Oral or intravenous cyclosporine is an immunosuppressant for transplantation of these and other organs and investigations are underway for its possible use in a variety of autoimmune diseases including rheumatoid arthritis, severe psoriasis, and Crohn s disease. Dose-dependent nephrotoxicity (261—264) remains the primary limitation of the dmg and necessitates close monitoring of patients, including measurement of dmg levels in blood. Cyclosporine research has been reviewed (265—274). 

The nurse reviews the results of all laboratory tests at the time they are reported. The primary health care provider is notified of the results before the administration of successive doses of an antineoplastic drug. If these tests indicate a severe depressant effect on the bone marrow or other test abnormalities, the primary health care provider may reduce the next drug dose or temporarily stop chemotherapy to allow the affected body systems to recover. 

In the periphery, CB1 is found in the adrenal glands, bone marrow, heart, lung, prostate, testes, thymus, tonsils, spleen, lymphocytes, phagocytes, smooth muscle, vascular endothelium, peripheral neurons (e.g., in the gut), kidneys, uterus, and sperm as reviewed by Schuel et al. (1999). 

Silk fibers or monolayers of silk proteins have a number of potential biomedical applications. Biocompatibility tests have been carried out with scaffolds of fibers or solubilized silk proteins from the silkworm Bombyx mori (for review see Ref. [38]). Some biocompatibility problems have been reported, but this was probably due to contamination with residual sericin. More recent studies with well-defined silkworm silk fibers and films suggest that the core fibroin fibers show in vivo and in vivo biocompatibility that is comparable to other biomaterials, such as polyactic acid and collagen. Altmann et al. [39] showed that a silk-fiber matrix obtained from properly processed natural silkworm fibers is a suitable material for the attachment, expansion and differentiation of adult human progenitor bone marrow stromal cells. Also, the direct inflammatory potential of silkworm silk was studied using an in vitro system [40]. The authors claimed that their silk fibers were mostly immunologically inert in short and long term culture with murine macrophage cells. 

Patients with frequent relapses despite apparently adequate prophylactic treatment should be reviewed carefully. Associated milk intolerance or coeliac disease need treatment on their merits. Colonoscopic evidence of dysplasia raises the question of undiagnosed malignancy. Occasionally the prophylactic agents themselves can cause watery diarrhoea (particularly olsalazine) or a hypersensitivity colitic disease. Prophylactic azathioprin should be considered in those in whom relapse is frequent despite use of aminosalicylates or if they are poorly tolerated. In the effective dose of 2 mg/kg adverse effects of bone marrow depression are uncommon, but still occur, and regular haematological review is essential (monthly or bi-monthly). Azathioprin-induced pancreatitis is an uncommon but well-recognised entity. 

Redo, L., Meyer, K.G., Pluta, L.J., Moss, O.R. Saronko, C. (1996) Assessment of 1,3-butadiene mutagenicity in the bone marrow of B6C3F1 lad transgenic mice (big blued A review of mutational spectrum and lad mutant frequency after a 5-day 625 ppm 1,3-butadiene exposure. Environ, mol. Mutag., 28, 424-429... 

Chlorodifluoromethane is mutagenic to Salmonella typhimurium but it did not induce either mutation or gene conversion in Saccharomyces cerevisiae. Chlorodifluoromethane did not induce mutations at the hprt locus or imscheduled DNA synthesis in mammalian cell lines in the presence or absence of an exogenous metabolic activation system. In vivo, it did not induce chromosomal aberrations in bone-marrow cells or dominant lethal effects (lARC, 1987b). These conclusions are supported by a more recent review (WHO, 1991). 

Chloro-1,1,1-trifluoroethane did not induce mutations in Salmonella typhimurium (lARC, 1986). 2-Chloro-1,1,1-trifluoroethane was reviewed by a WHO task group, which also concluded that it did not induce mutations in S. typhimurium, but additionally that it did not induce chromosomal aberrations in rat bone-marrow cells in vivo. Dominant lethal effects were observed in two of three studies in male mice (WHO, 1992). 

As well reviewed elsewhere [2], the control exerted by 5a-reduced steroids on erythropoiesis is best explained by transcriptional control of the erythropoietin gene. Certainly, such androgens are actively concentrated in the nuclear chromatin of bone marrow, both in vivo and in vitro. By contrast, the situation is entirely different with respect to 5/3-reduced steroids. In the embryonic and fetal organs of many animals, aetiocholanolone or 5/3-DHT regulate the appearance of a 5 cap-recognition protein, without which the translation of the mRNAs for haemoglobin E (embry-... 

After subcutaneous or intravenous administration, PS ODNs tend to accumulate in kidney, liver, spleen, bone marrow, and lymph nodes (reviewed in [1]). While the kidney generally accumulates the greatest concentration of... 

---